| 发明名称 |
Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| 摘要 |
Abstract: The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease. 4198132_1 (GHMatters) P79590.AU |
| 申请公布号 |
AU2013203094(B2) |
申请公布日期 |
2016.02.25 |
| 申请号 |
AU20130203094 |
申请日期 |
2013.04.09 |
| 申请人 |
TAKEDA GMBH |
发明人 |
WOLLIN, STEFAN-LUTZ;WOHLSEN, ANDREA;BRAUN, CLEMENS;MARX, DEGENHARD |
| 分类号 |
A61K31/44;A61K31/22;A61K31/277;A61K31/343;A61K31/352;A61K31/366;A61K31/40;A61K31/405;A61K31/437;A61K31/4439;A61K31/453;A61K31/502;A61K31/505;A61P11/00 |
主分类号 |
A61K31/44 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
